info@allievapharma.com


  • 24/7
    Customer Service
  • ISO 9001
    Certification Company
  • WHO-GMP
    Certified Company
OUR CATALOGUE OUR CATALOGUE

    • Product Details

    Afatinib Tablets IP 40mg

    Afatinib Tablets IP 40mg


    Brand NameAFALIEVA 40MG
    CompositionAfatinib Tablets IP 40mg
    Manufacture ByAllieva Pharma Private Limited
    FormTablet
    PackingBtl (28 tab)
    Country Of OriginIndia

    ENQUIRY! Enquire via WhatsApp

    Description

    Description

    AFALIEVA 40 mg contains Afatinib, an oral irreversible ErbB family tyrosine kinase inhibitor (TKI). It blocks EGFR (ErbB1) and HER2 (ErbB2) signaling by covalently binding to the receptor, thereby inhibiting tumor cell growth and survival. Afatinib is effective against tumors with EGFR activating mutations.

    Uses

    Afatinib is indicated for:

    1. Metastatic Non-Small Cell Lung Cancer (NSCLC)
         – With EGFR exon 19 deletion or exon 21 (L858R) substitution mutations

    2. Squamous Cell Carcinoma of the Lung
         – After failure of platinum-based chemotherapy (selected patients)

    Side Effects

    Common side effects:

       •  Diarrhea

       •  Acneiform skin rash

       •  Stomatitis / mouth ulcers

       •  Paronychia (nail infections)

       •  Dry skin

    Serious side effects:

       •  Severe diarrhea leading to dehydration

       •  Interstitial lung disease (rare)

       •  Hepatotoxicity

     Early management of diarrhea and skin toxicity is important.

    Dosage

    Standard adult dose:

       • 40 mg once daily

     Dose may be reduced to 30 mg or 20 mg based on tolerability.

    24/7 Clients Support

    Best Price

    Quality Assurance
    function changeImage(elem, src) { document.getElementById("mainImage").src = src; document.querySelectorAll(".thumbnail-container img").forEach(img => img.style.border = "2px solid transparent"); elem.style.border = "2px solid #007bff"; }
    Allieva Pharma Event